Rocepafant

DB19947ExperimentalSmall molecule

Rocepafant is a small molecule drug. The usage of the INN stem '-pafant' in the name indicates that Rocepafant is a platelet-activating factor antagonist. Rocepafant has a monoisotopic molecular weight...

Formula / weight: C₂₆H₂₃ClN₆OS₂ · 535.08 g/mol (avg)

Resolves to

Compound

UNII4KGX1STY2NCAS132418-36-1ChEMBLCHEMBL2105298

Structure

InChIKeyWBGAFGNZNGJVNW-UHFFFAOYSA-NSMILESCOC1=CC=C(NC(=S)N2CCC3=C(C2)SC2=C3C(=NCC3=NN=C(C)N23)C2=CC=CC=C2Cl)C=C1

Targets

P25105PTAFR

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Rocepafant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account